Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $78 | 35 days | |
5 mg | $348 | 35 days | |
10 mg | $595 | 35 days | |
25 mg | $1,330 | 35 days |
Description | (S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM. |
Molecular Weight | 401.63 |
Formula | C26H43NO2 |
Cas No. | 1246776-22-6 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMF: 30 mg/mL Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL DMSO: 25 mg/mL Ethanol: 30 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.